Advertisement
News
Subscribe to MDT Magazine News

Brain 'GPS' illuminated in migratory monarch butterflies

January 26, 2011 7:38 am | by EurekAlert | Comments

(Cell Press) A new study takes a close look at the brain of the migratory monarch butterfly to better understand how these remarkable insects use an internal compass and skylight cues to navigate from eastern North America to Mexico each fall. The research, published by Cell Press...

TOPICS:

Perrigo Company Announces Quarterly Dividend

January 26, 2011 7:33 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., Jan. 26, 2011 /- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.07 per share, payable on March 15, 2011 to shareholders of record on February 25, 2011. Perrigo Company is a leading global healthcare...

TOPICS:

Sysmex America Appoints Vice President of Sales

January 26, 2011 7:33 am | by Bio-Medicine.Org | Comments

MUNDELEIN, Ill., Jan. 26, 2011 /- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced that Andrew (Andy) Hay has been named as Sysmex America's Vice President of Sales effective immediately.  Hay, a long-time Sysmex...

TOPICS:
Advertisement

Correction: New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services

January 26, 2011 7:33 am | by Bio-Medicine.Org | Comments

ALBUQUERQUE, N.M., Jan. 26, 2011 /- New Mexico Software, Inc. (OTC Bulletin Board: NMXC ), a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the implementation of a software module that gives the...

TOPICS:

Summary Box: WellPoint 4Q tops expectations

January 26, 2011 6:45 am | by The Associated Press | Comments

THE RESULTS: Health insurer WellPoint Inc. earned $548.8 million, or $1.40 per share, in the fourth quarter of 2010 on $14.42 billion in operating revenue. Earnings fell below the company's performance in the same quarter of 2009, when it had a big gain from a subsidiary sale.THE UPSIDE: Adjusted...

Breast Implants: FDA Review Indicates Possible Association With A Rare Cancer

January 26, 2011 6:37 am | by U.S. Food & Drug Administration | Comments

Data reviewed by the FDA suggest that patients with breast implants may have a very small but significant risk of ALCL in the scar capsule adjacent to the implant.

FDA Medical Device Safety Communication: Reports of Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants

January 26, 2011 6:36 am | by U.S. Food & Drug Administration | Comments

The FDA is issuing this communication to inform health care providers and the public about a possible association between breast implants and a type of anaplastic large cell lymphoma (ALCL). Although ALCL is extremely rare, the FDA believes that women...

Long-Term European Data Released for SUPERA® Stent from IDEV Technologies

January 26, 2011 6:35 am | by Bio-Medicine.Org | Comments

LEIPZIG, Germany, Jan. 26, 2011 /- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced the release of two-year European data from the prominent Leipzig Registry, which tracks...

TOPICS:
Advertisement

Using Technology to Maximize the Clinician's Role

January 26, 2011 6:33 am | by Diagnostic Imaging | Comments

The iPad and other mobile devices are able to provide access to an enormous amount of information quickly. When combined with the knowledge and expertise of a skilled professional such as a doctor, these tools are amplified in their efficiency. With an iPad, every physician can become an...

TOPICS:

New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

ALBUQUERQUE, N.M., Jan. 26, 2011 /- New Mexico Software, Inc. (OTC Bulletin Board: NMXC ), a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the implementation of a software module that gives the...

TOPICS:

QPS Expands Phase 1 and Bioanalytical Capability by Acquisition of Bioserve, India

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

NEWARK, Del. and HYDERABAD, India, Jan. 26, 2011 /- QPS, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the acquisition of a majority stake in Bioserve Clinical...

TOPICS:

MedCath Corporation to Release First Quarter Results

January 26, 2011 6:33 am | by Bio-Medicine.Org | Comments

CHARLOTTE, N.C., Jan. 26, 2011 /- MedCath Corporation (Nasdaq: MDTH ) will issue a press release after the market closes on February 9, 2011 to announce results from its first fiscal quarter ended December 31, 2010. MedCath has elected not to host a conference call to review its first...

TOPICS:

Avantra Biosciences Launches Multiplex System for Faster, Easier Quantification of Cancer Protein Biomarkers

January 26, 2011 6:32 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Jan. 26, 2011 /- Avantra® Biosciences, a leading innovator in protein diagnostics, announced today their first shipments of the new Q400 Biomarker Workstation and the innovative Angio Qx™ BioChip Immunoassay. The system provides quantitative protein biomarker...

TOPICS:

Research shows how pathogenic bacteria hide inside host cells

January 26, 2011 5:31 am | by EurekAlert | Comments

(Wiley-Blackwell) A new study into Staphylococcus aureus, the bacterium which is responsible for severe chronic infections worldwide, reveals how bacteria have developed a strategy of hiding within host cells to escape the immune system as well as many antibacterial treatments. The...

TOPICS:

Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Elementâ„¢ Everolimus-Eluting Stent

January 26, 2011 3:32 am | by Boston Scientific | Comments

PLATINUM China trial to support Chinese regulatory approval of next-generation platinum chromium stent

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading